BioLife Solutions, Inc. (BLFS)
Company Info
US09062W2044
09062W204
Nov 22, 1989
Highlights
$1.06B
-$0.19
65.38
$79.42M
$60.76M
$3.39M
$18.70 - $29.55
$31.22
12.25%
5.96
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
BioLife Solutions, Inc. (BLFS) returned -14.02% year-to-date (YTD) and 3.38% over the past 12 months. Over the past 10 years, BLFS delivered an annualized return of 27.74%, outperforming the S&P 500 benchmark at 10.84%.
BLFS
-14.02%
-9.67%
-17.82%
3.38%
14.86%
6.29%
27.74%
^GSPC (Benchmark)
0.52%
6.32%
-1.44%
12.25%
12.45%
14.20%
10.84%
Monthly Returns
The table below presents the monthly returns of BLFS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 5.18% | -12.10% | -4.83% | 5.56% | -7.42% | -14.02% | |||||||
| 2024 | 4.62% | -0.59% | 9.76% | -5.44% | 22.46% | -0.23% | 12.09% | 7.74% | -3.25% | -6.55% | 17.39% | -5.50% | 59.75% |
| 2023 | 28.79% | -0.77% | -6.49% | -19.26% | 32.97% | -5.35% | -10.05% | -33.55% | 4.54% | -26.86% | 22.48% | 31.37% | -10.71% |
| 2022 | -19.94% | -21.25% | -3.28% | -44.26% | 8.29% | 0.66% | 39.54% | 22.52% | -3.64% | 3.38% | -9.99% | -14.03% | -51.17% |
| 2021 | -4.94% | 3.45% | -8.23% | -3.06% | -4.56% | 33.62% | 5.37% | 24.43% | -27.48% | 25.59% | -28.20% | -2.33% | -6.57% |
| 2020 | -14.77% | 2.61% | -32.86% | 15.05% | 50.50% | -0.61% | 18.23% | 10.29% | 35.74% | -0.79% | 25.36% | 10.84% | 146.54% |
| 2019 | 21.95% | 29.93% | -6.14% | -6.43% | 5.91% | -4.40% | 12.51% | 8.50% | -19.65% | 2.32% | -1.53% | -3.40% | 34.50% |
| 2018 | -9.67% | -4.61% | -0.77% | 40.94% | 48.13% | 6.54% | 67.05% | 25.71% | -26.96% | -27.31% | -5.90% | 0.50% | 100.50% |
| 2017 | 14.89% | 4.86% | 7.73% | -3.35% | 6.44% | 11.16% | 44.35% | 37.39% | 20.46% | 0.70% | -1.04% | 5.45% | 272.60% |
| 2016 | -8.29% | -13.07% | 5.78% | 0.00% | -13.93% | 1.59% | 28.75% | -15.05% | 5.14% | -13.04% | -2.01% | 2.71% | -25.79% |
| 2015 | 7.93% | 9.04% | -16.58% | 15.53% | 3.59% | 1.20% | 16.41% | 21.15% | -23.27% | 5.21% | 1.35% | -3.55% | 32.32% |
| 2014 | -14.29% | -3.33% | -46.98% | -21.68% | -19.72% | -1.72% | 16.23% | -10.57% | -11.39% | 4.77% | 0.00% | -25.45% | -80.48% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of BLFS is 51, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for BioLife Solutions, Inc. (BLFS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the BioLife Solutions, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the BioLife Solutions, Inc. was 99.98%, occurring on Oct 15, 2008. The portfolio has not yet recovered.
The current BioLife Solutions, Inc. drawdown is 98.38%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.98% | Nov 6, 1991 | 4014 | Oct 15, 2008 | — | — | — |
| -33.8% | Nov 28, 1989 | 275 | Jan 3, 1991 | 69 | Apr 12, 1991 | 344 |
| -21.74% | Sep 25, 1991 | 15 | Oct 15, 1991 | 3 | Oct 18, 1991 | 18 |
| -21.36% | Apr 17, 1991 | 2 | Apr 18, 1991 | 15 | May 9, 1991 | 17 |
| -15.63% | May 20, 1991 | 68 | Aug 23, 1991 | 14 | Sep 13, 1991 | 82 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of BioLife Solutions, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of BioLife Solutions, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 201.4% positive surprise.
Valuation
The Valuation section provides an overview of how BioLife Solutions, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for BLFS compared to other companies in the Medical Instruments & Supplies industry. BLFS currently has a PEG ratio of 65.4. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for BLFS relative to other companies in the Medical Instruments & Supplies industry. Currently, BLFS has a P/S ratio of 12.1. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for BLFS in comparison with other companies in the Medical Instruments & Supplies industry. Currently, BLFS has a P/B value of 3.0. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |